TissueGen

12/09/2019

12/09/2019

TissueGen‘s chief scientist and co-founder, Kevin Nelson, tells Drug Delivery Business News the story behind the company he founded in 2000 and its drug delivery technology, the Elute fiber.

TissueGen‘s chief scientist and co-founder, Kevin Nelson, told Drug Delivery Business News the story behind the company he founded in 2000 and its drug delivery technology, the Elute fiber. DDBN: How did TissueGen get its start? Nelson: In 1996, while faculty in biomedical engineering at The Unive...

12/09/2019

Biologics and fivers can advance nerve generation! TissueGen is at the forefront of this innovative work.

Dr. Kevin Nelson, founder and CSO, TissueGen explains how biologics and fibres could make for an entirely new approach to nerve generation, advanced drug delivery and tissue engineering.

12/09/2019

TissueGen Wins 2017 Future Textiles Award for Most Innovative Small Company.

DALLAS, May 18, 2017 (GLOBE NEWSWIRE) -- TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug...